clinical trial · NCT00373672
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
SchizophreniaSchizoaffective Disorderarmodafinil (Nuvigil)placebo
brief summary
This is a six week, double blind,placebo controlled study for patients with schizophrenia or schizoaffective disorder treated with an atypical antipsychotic for at least two months. Subjects will be randomized to take armodafinil (Nuvigil) or placebo along with their current antipsychotic and tested at baseline and week 6 for differences in memory, attention and problem-solving ability. Changes in weight during the six week study will also be tracked.
started
Aug 1, 2006
primary completion
Jan 1, 2010
completion
Jan 1, 2010
last updated
Aug 5, 2025
official title
Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol